Every parliamentary written question tabled by Luke Evans this session, with the full answer and department. See how every department answers, or back to the MP page.
Showing 1–20 of 966 · this parliament
Pursuant to the Answer of 2 July 2026 to Question 12047 on Employment: Disability, what recent assessment he has made of the impact of (a) work coaches, (b) disability employment advisers at Jobcentres and (c) access to work grants on the number of people with disabilities in work.
Awaiting answer.
Pursuant to the Answer of 2 July 2026 to Question 12047 on Employment: Disability, what recent assessment he has made of the impact of employment advisors in (a) NHS Talking Therapies, (b) Connect to Work and (c) Workwell on the number of people with disabilities in work.
Awaiting answer.
Pursuant to the Answer of 2 July 2026 to Question 12047 on Employment: Disability, what recent conversations he has had with (a) other government departments and (b) third party bodies to support efforts to champion people with disabilities into work.
Awaiting answer.
Pursuant to the Answer of 2 July 2026 to Question 12047 on Employment: Disability, what assessment he has made of the potential challenges faced by his Department to support people with disabilities into work and reduce the disability employment gap.
Awaiting answer.
How much undergraduate medical tariff funding has been withheld or unaccounted for, for each of the past five years.
Awaiting answer.
Whether he has made an assessment on the potential impact of introducing specific diagnostic or reporting time standards for patients with a limited or terminal prognosis.
Awaiting answer.
For what reason NHS England ceased collecting accountability reports on undergraduate medical tariff funding, and what alternative oversight arrangements are in place.
Awaiting answer.
What steps he is taking to ensure that undergraduate medical tariff funding is spent on frontline teaching and training for medical students.
Awaiting answer.
How much and what proportion of undergraduate medical tariff funding is used to support (a) wider NHS service delivery and (b) educational activities.
Awaiting answer.
What assessment he has made of whether NHS England’s diagnostic imaging turnaround time guidance is sufficient to meet the needs of patients with a recognised terminal diagnosis.
Awaiting answer.
What guidance exists for NHS providers on the timely communication of significant diagnostic findings to patients and their families where deterioration or recurrence of cancer is suspected.
Awaiting answer.
Whether the forthcoming Palliative Care and End-of-Life Care Modern Service Framework will include provisions relating to the timeliness of diagnostic results and communication for patients with a limited prognosis.
Awaiting answer.
Whether NHS England continues to collect annual accountability reports from NHS trusts on the expenditure of undergraduate medical tariff funding.
Awaiting answer.
Whether patients with recognised palliative or end-of-life care needs are subject to specific identification or prioritisation processes within accident and emergency departments.
Awaiting answer.
What assessment he has made of levels of regional variation in access to fezolinetant across England.
Awaiting answer.
Whether national guidance has been issued to Integrated Care Boards on the prescribing of fezolinetant following its approval for NHS use.
Awaiting answer.
What steps he is taking to ensure that patients are not disadvantaged when accessing NHS care after accessing treatment privately due to a previous lack of NHS availability.
Awaiting answer.
What steps he is taking to ensure consistent access across Integrated Care Boards to non-hormonal menopause treatments, including fezolinetant.
Awaiting answer.
What guidance exists on shared care arrangements for patients seeking to transition from privately obtained medication to NHS prescriptions where those treatments later become available on the NHS.
Awaiting answer.
Whether he has had discussions with NHS England on access to fezolinetant within Leicester, Leicestershire and Rutland Integrated Care Board.
Awaiting answer.